MFG-E8 inhibits Aβ-induced microglial production of cathelicidin-related antimicrobial peptide: A suitable target against Alzheimer's disease

Cell Immunol. 2018 Sep:331:59-66. doi: 10.1016/j.cellimm.2018.05.008. Epub 2018 May 24.

Abstract

Neuroinflammation plays a pivotal role in the incidence and progression of Alzheimer's disease (AD). Cathelicidin-related antimicrobial peptide (CRAMP) is critically involved in the innate neuronal responses of chronic neuroinflammation in AD and thus plays a key role in the disease. Here, we show that Aβ42 induced microglial production of CRAMP, which was effectively inhibited by milk-fat globule-epidermal growth factor 8 (MFG-E8). Production of CRAMP was associated with activation of ERK1/2, p38 and phospho-P65-NF-kB upregulation. Additionally, the phosphorylation of these signaling proteins was also reversed by MFG-E8. Pre-incubation with signaling inhibitors confirmed that MFG-E8 has a regulatory role on CRAMP through MAPK and NF-kB signaling pathways. MFG-E8 treatment may thus be a potential pharmacotherapy for chronic inflammation in AD.

Keywords: Alzheimer’s disease; Aβ42; CRAMP; MFG-E8; Microglia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Animals, Newborn
  • Antigens, Surface / pharmacology*
  • Antimicrobial Cationic Peptides / antagonists & inhibitors*
  • Antimicrobial Cationic Peptides / genetics
  • Antimicrobial Cationic Peptides / metabolism
  • Cathelicidins
  • Cells, Cultured
  • Gene Expression / drug effects
  • Inflammation / drug therapy
  • Inflammation / genetics
  • Inflammation / metabolism
  • Mice, Inbred C57BL
  • Microglia / drug effects*
  • Microglia / metabolism
  • Milk Proteins / pharmacology*
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Peptide Fragments / toxicity*
  • Phosphorylation / drug effects
  • Signal Transduction / drug effects

Substances

  • Amyloid beta-Peptides
  • Antigens, Surface
  • Antimicrobial Cationic Peptides
  • Mfge8 protein, mouse
  • Milk Proteins
  • NF-kappa B
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Mitogen-Activated Protein Kinases
  • Cathelicidins